Stay updated on TITAN-TCC Nivolumab Tailored Immunotherapy Clinical Trial

Sign up to get notified when there's something new on the TITAN-TCC Nivolumab Tailored Immunotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TITAN-TCC Nivolumab Tailored Immunotherapy Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; Revision: v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-18T18:09:08.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision: v3.4.3 added and Revision: v3.4.2 removed. This change does not alter core study information or user actions.
    Difference
    0.0%
    Check dated 2026-03-11T17:25:36.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A publication citation was added to the Publications section and then removed, resulting in no net change to the page content.
    Difference
    0.0%
    Check dated 2026-03-04T14:33:12.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the prior Notice about government funding lapse and Revision: v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-11T09:16:52.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Added a JAMA Oncology 2024 publication citation related to TITAN-TCC. Updated the record to revision v3.4.1 and removed the Erratum entry for that publication.
    Difference
    0.4%
    Check dated 2026-02-04T04:58:03.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now shows the glossary by default. The QC and FEAR Act-related labels have been standardized and the revision tag updated from v3.3.4 to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T03:28:18.000Z thumbnail image

Stay in the know with updates to TITAN-TCC Nivolumab Tailored Immunotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TITAN-TCC Nivolumab Tailored Immunotherapy Clinical Trial page.